{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T05:57:39Z","timestamp":1757311059394,"version":"3.37.3"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T00:00:00Z","timestamp":1731024000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T00:00:00Z","timestamp":1731024000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Insights Imaging"],"abstract":"<jats:sec>\n                <jats:title>Abstract<\/jats:title>\n                <jats:p>Percutaneous image-guided ablation techniques are a consolidated therapeutic alternative for patients with high preoperative surgical risk for the management of oncological diseases in multiple body districts. Each technique has both pros and cons according to the type of energy delivered, mechanism of action, and site of application. The present article reviews the most recent literature results on ablation techniques applied in the field of genitourinary diseases (kidney, adrenal glands, prostate, and uterus), describing the advantages of the use of each technique and their technical limitations and summarizing the major recommendations from an international consensus meeting.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Critical relevant statement<\/jats:title>\n                <jats:p>The article critically evaluates the efficacy and safety of ablation therapies for various genitourinary tract diseases, demonstrating their potential to improve patient outcomes and advance clinical radiology by offering minimally invasive, effective alternatives to traditional surgical treatments.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Key Points<\/jats:title>\n                <jats:p><jats:list list-type=\"bullet\">\n                  <jats:list-item>\n                    <jats:p>Ablation therapies are effective alternatives to surgery for renal cell carcinoma.<\/jats:p>\n                  <\/jats:list-item>\n                  <jats:list-item>\n                    <jats:p>Ablation techniques offer effective treatment for intermediate-risk prostate cancer.<\/jats:p>\n                  <\/jats:list-item>\n                  <jats:list-item>\n                    <jats:p>Ablation is a promising tool for adrenal tumor management.<\/jats:p>\n                  <\/jats:list-item>\n                  <jats:list-item>\n                    <jats:p>Ablation reduces fibroid symptoms and volume, offering an alternative to surgery.<\/jats:p>\n                  <\/jats:list-item>\n                <\/jats:list><\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Graphical Abstract<\/jats:title>\n                \n              <\/jats:sec>","DOI":"10.1186\/s13244-024-01841-2","type":"journal-article","created":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T08:54:09Z","timestamp":1731056049000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Proceedings from an international consensus meeting on ablation in urogenital diseases"],"prefix":"10.1186","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2791-481X","authenticated-orcid":false,"given":"Roberto","family":"Iezzi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Contegiacomo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"De Filippis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew J.","family":"Gunn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Atwell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy","family":"Mcclure","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhang","family":"Jing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Posa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Rita","family":"Scrofani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Maresca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David C.","family":"Madoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shraga Nahum","family":"Goldberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexis","family":"Kelekis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitri","family":"Filippiadis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evis","family":"Sala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muneeb","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,11,8]]},"reference":[{"key":"1841_CR1","first-page":"133","volume":"19","author":"DP Murphy","year":"2001","unstructured":"Murphy DP, Gill IS (2001) Energy-based renal tumor ablation: a review. Semin Urol Oncol 19:133\u2013140","journal-title":"Semin Urol Oncol"},{"key":"1841_CR2","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1159\/000102478","volume":"39","author":"LW Organ","year":"1976","unstructured":"Organ LW (1976) Electrophysiologic principles of radiofrequency lesion making. Appl Neurophysiol 39:69\u201376. https:\/\/doi.org\/10.1159\/000102478","journal-title":"Appl Neurophysiol"},{"key":"1841_CR3","doi-asserted-by":"publisher","first-page":"S179","DOI":"10.1016\/j.jvir.2010.04.008","volume":"21","author":"K Hong","year":"2010","unstructured":"Hong K, Georgiades C (2010) Radiofrequency ablation: mechanism of action and devices. J Vasc Interv Radiol 21:S179\u2013S186. https:\/\/doi.org\/10.1016\/j.jvir.2010.04.008","journal-title":"J Vasc Interv Radiol"},{"key":"1841_CR4","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1159\/000111718","volume":"72","author":"P Liang","year":"2007","unstructured":"Liang P, Wang Y (2007) Microwave ablation of hepatocellular carcinoma. Oncology 72:124\u2013131. https:\/\/doi.org\/10.1159\/000111718","journal-title":"Oncology"},{"key":"1841_CR5","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/s0090-4295(98)00169-1","volume":"52","author":"SC Campbell","year":"1998","unstructured":"Campbell SC, Krishnamurthi V, Chow G et al (1998) Renal cryosurgery: experimental evaluation of treatment parameters. Urology 52:29\u201334. https:\/\/doi.org\/10.1016\/s0090-4295(98)00169-1","journal-title":"Urology"},{"key":"1841_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-016-2332-z","volume":"16","author":"MJ Scheltema","year":"2016","unstructured":"Scheltema MJ, van den Bos W, de Bruin DM et al (2016) Focal vs extended ablation in localized prostate cancer with irreversible electroporation; a multi-center randomized controlled trial. BMC Cancer 16:299. https:\/\/doi.org\/10.1186\/s12885-016-2332-z","journal-title":"BMC Cancer"},{"key":"1841_CR7","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s00270-014-0846-9","volume":"37","author":"K Katsanos","year":"2014","unstructured":"Katsanos K, Mailli L, Krokidis M, McGrath A, Sabharwal T, Adam A (2014) Systematic review and meta-analysis of thermal ablation versus surgical nephrectomy for small renal tumours. Cardiovasc Intervent Radiol 37:427\u2013437. https:\/\/doi.org\/10.1007\/s00270-014-0846-9","journal-title":"Cardiovasc Intervent Radiol"},{"key":"1841_CR8","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jvir.2017.08.013","volume":"29","author":"JR Rivero","year":"2018","unstructured":"Rivero JR, De La Cerda J 3rd, Wang H et al (2018) Partial nephrectomy versus thermal ablation for clinical stage T1 renal masses: systematic review and meta-analysis of more than 3900 patients. J Vasc Interv Radiol 29:18\u201329. https:\/\/doi.org\/10.1016\/j.jvir.2017.08.013","journal-title":"J Vasc Interv Radiol"},{"key":"1841_CR9","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1055\/s-0035-1567133","volume":"189","author":"D Vollherbst","year":"2017","unstructured":"Vollherbst D, Bertheau R, Kauczor HU, Radeleff BA, Pereira PL, Sommer CM (2017) Erratum: treatment failure after image-guided percutaneous radiofrequency ablation (RFA) of renal tumors\u2014a systematic review with description of type, frequency, risk factors and management. Rofo 189:e1. https:\/\/doi.org\/10.1055\/s-0035-1567133","journal-title":"Rofo"},{"key":"1841_CR10","doi-asserted-by":"publisher","first-page":"938","DOI":"10.3348\/kjr.2018.19.5.938","volume":"19","author":"SH Choi","year":"2018","unstructured":"Choi SH, Kim JW, Kim JH, Kim KW (2018) Efficacy and safety of microwave ablation for malignant renal tumors: an updated systematic review and meta-analysis of the literature since 2012. Korean J Radiol 19:938. https:\/\/doi.org\/10.3348\/kjr.2018.19.5.938","journal-title":"Korean J Radiol"},{"key":"1841_CR11","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.urolonc.2022.04.002","volume":"40","author":"T Yanagisawa","year":"2022","unstructured":"Yanagisawa T, Mori K, Kawada T et al (2022) Differential efficacy of ablation therapy versus partial nephrectomy between clinical T1a and T1b renal tumors: a systematic review and meta-analysis. Urol Oncol 40:315\u2013330. https:\/\/doi.org\/10.1016\/j.urolonc.2022.04.002","journal-title":"Urol Oncol"},{"key":"1841_CR12","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1089\/end.2023.0342","volume":"37","author":"J Wu","year":"2023","unstructured":"Wu J, Sami S, Lajkosz K, Kishibe T, Ordon M (2023) An updated systematic review and meta-analysis on the technical, oncologic, and safety outcomes of microwave ablation in patients with renal cell carcinoma. J Endourol 37:1314\u20131330. https:\/\/doi.org\/10.1089\/end.2023.0342","journal-title":"J Endourol"},{"key":"1841_CR13","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1089\/end.2017.0791","volume":"32","author":"OM Aboumarzouk","year":"2018","unstructured":"Aboumarzouk OM, Ismail M, Breen DJ, Van Strijen M et al (2018) Laparoscopic vs percutaneous cryotherapy for renal tumors: a systematic review and meta-analysis. J Endourol 32:177\u2013183. https:\/\/doi.org\/10.1089\/end.2017.0791","journal-title":"J Endourol"},{"key":"1841_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.urology.2023.06.001","volume":"180","author":"T McClure","year":"2023","unstructured":"McClure T, Lansing A, Ferko N et al (2023) A comparison of microwave ablation and cryoablation for the treatment of renal cell carcinoma: a systematic literature review and meta-analysis. Urology 180:1\u20138. https:\/\/doi.org\/10.1016\/j.urology.2023.06.001","journal-title":"Urology"},{"key":"1841_CR15","doi-asserted-by":"publisher","unstructured":"Dong L, Liang WY, Ya L, Yang L, Qiang W A (2022) Systematic review and meta-analysis of minimally invasive partial nephrectomy versus focal therapy for small renal masses. Front Oncol. https:\/\/doi.org\/10.3389\/fonc.2022.732714","DOI":"10.3389\/fonc.2022.732714"},{"key":"1841_CR16","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1055\/s-0039-1697641","volume":"36","author":"AR Lewis","year":"2019","unstructured":"Lewis AR, Padula CA, McKinney JM, Toskich BB (2019) Ablation plus transarterial embolic therapy for hepatocellular carcinoma larger than 3\u2009cm: science, evidence, and future directions. Semin Intervent Radiol 36:303\u2013309. https:\/\/doi.org\/10.1055\/s-0039-1697641","journal-title":"Semin Intervent Radiol"},{"key":"1841_CR17","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1159\/000447230","volume":"12","author":"AJ Gunn","year":"2018","unstructured":"Gunn AJ, Mullenbach BJ, Poundstone MM, Gordetsky JB, Underwood ES, Rais-Bahrami S (2018) Trans-arterial embolization of renal cell carcinoma prior to percutaneous ablation: technical aspects, institutional experience, and brief review of the literature. Curr Urol 12:43\u201349. https:\/\/doi.org\/10.1159\/000447230","journal-title":"Curr Urol"},{"key":"1841_CR18","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1258\/ar.2012.110413","volume":"53","author":"Y Nakasone","year":"2012","unstructured":"Nakasone Y, Kawanaka K, Ikeda O, Tamura Y, Yamashita Y (2012) Sequential combination treatment (arterial embolization and percutaneous radiofrequency ablation) of inoperable renal cell carcinoma: single-center pilot study. Acta Radiol 53:410\u2013414. https:\/\/doi.org\/10.1258\/ar.2012.110413","journal-title":"Acta Radiol"},{"key":"1841_CR19","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.crad.2015.10.012","volume":"71","author":"XH Duan","year":"2016","unstructured":"Duan XH, Li YS, Han XW et al (2016) C-arm CT-guided renal arterial embolisation followed by radiofrequency ablation for treatment of patients with unresectable renal cell carcinoma. Clin Radiol 71:79\u201385. https:\/\/doi.org\/10.1016\/j.crad.2015.10.012","journal-title":"Clin Radiol"},{"key":"1841_CR20","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1007\/s10147-022-02224-7","volume":"27","author":"H Gobara","year":"2022","unstructured":"Gobara H, Matsui Y, Uka M et al (2022) Percutaneous cryoablation combined with prior transcatheter arterial embolization for renal cell carcinomas of 3\u2009cm or larger: a prospective study. Int J Clin Oncol 27:1589\u20131595. https:\/\/doi.org\/10.1007\/s10147-022-02224-7","journal-title":"Int J Clin Oncol"},{"key":"1841_CR21","doi-asserted-by":"publisher","unstructured":"Sommer CM, Pallwein-Prettner L, Vollherbst DF et al (2016) Transarterial embolization (TAE) as add-on to percutaneous radiofrequency ablation (RFA) for the treatment of renal tumors: review of the literature, overview of state-of-the-art embolization materials and further perspective of advanced image-guided tumor ablation. Eur J Radiol. https:\/\/doi.org\/10.1016\/j.ejrad.2016.10.024","DOI":"10.1016\/j.ejrad.2016.10.024"},{"key":"1841_CR22","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1053\/j.tvir.2010.02.004","volume":"13","author":"AM Venkatesan","year":"2010","unstructured":"Venkatesan AM, Locklin J, Dupuy DE, Wood BJ (2010) Percutaneous ablation of adrenal tumors. Tech Vasc Interv Radiol 13:89\u201399. https:\/\/doi.org\/10.1053\/j.tvir.2010.02.004","journal-title":"Tech Vasc Interv Radiol"},{"key":"1841_CR23","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.jvir.2020.12.010","volume":"32","author":"S Pan","year":"2021","unstructured":"Pan S, Baal JD, Chen WC et al (2021) Image-guided percutaneous ablation of adrenal metastases: a meta-analysis of efficacy and safety. J Vasc Interv Radiol 32:527\u2013535.e1. https:\/\/doi.org\/10.1016\/j.jvir.2020.12.010","journal-title":"J Vasc Interv Radiol"},{"key":"1841_CR24","doi-asserted-by":"publisher","unstructured":"Zhang JH, Fu YF, Wang JY (2022) Percutaneous ablation for adrenal metastases: a systematic review and meta-analysis. Wideochir Inne Tech Maloinwazyjne. https:\/\/doi.org\/10.5114\/wiitm.2022.119585","DOI":"10.5114\/wiitm.2022.119585"},{"key":"1841_CR25","doi-asserted-by":"publisher","first-page":"60","DOI":"10.25259\/JCIS_98_2020","volume":"10","author":"G Rosiak","year":"2020","unstructured":"Rosiak G, Milczarek K, Konecki D, Otto M, Rowinski O, Zgliczynski W (2020) Percutaneous bilateral adrenal radiofrequency ablation in severe adrenocorticotropic hormone-dependent cushing syndrome. J Clin Imaging Sci 10:60. https:\/\/doi.org\/10.25259\/JCIS_98_2020","journal-title":"J Clin Imaging Sci"},{"key":"1841_CR26","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1016\/j.jvir.2019.04.039","volume":"30","author":"K-W Liang","year":"2019","unstructured":"Liang K-W, Jahangiri Y, Tsao T-F, Tyan Y-S, Huang H-H (2019) Effectiveness of thermal ablation for aldosterone-producing adrenal adenoma: a systematic review and meta-analysis of clinical and biochemical parameters. J Vasc Interv Radiol 30:1335\u20131342.e1. https:\/\/doi.org\/10.1016\/j.jvir.2019.04.039","journal-title":"J Vasc Interv Radiol"},{"key":"1841_CR27","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.jvir.2015.11.034","volume":"27","author":"FJ Fintelmann","year":"2016","unstructured":"Fintelmann FJ, Tuncali K, Puchner S et al (2016) Catecholamine surge during image-guided ablation of adrenal gland metastases: predictors, consequences, and recommendations for management. J Vasc Interv Radiol 27:395\u2013402. https:\/\/doi.org\/10.1016\/j.jvir.2015.11.034","journal-title":"J Vasc Interv Radiol"},{"key":"1841_CR28","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1007\/s00270-010-0078-6","volume":"34","author":"K Yamakado","year":"2011","unstructured":"Yamakado K, Takaki H, Uchida K, Nakatsuka A, Shiraishi T, Takeda K (2011) Adrenal radiofrequency ablation in swine: change in blood pressure and histopathologic analysis. Cardiovasc Intervent Radiol 34:839\u2013844. https:\/\/doi.org\/10.1007\/s00270-010-0078-6","journal-title":"Cardiovasc Intervent Radiol"},{"key":"1841_CR29","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1148\/radiol.10100631","volume":"258","author":"BT Welch","year":"2011","unstructured":"Welch BT, Atwell TD, Nichols DA et al (2011) Percutaneous image-guided adrenal cryoablation: procedural considerations and technical success. Radiology 258:301\u2013307. https:\/\/doi.org\/10.1148\/radiol.10100631","journal-title":"Radiology"},{"key":"1841_CR30","doi-asserted-by":"publisher","first-page":"132","DOI":"10.4158\/EP161498.OR","volume":"23","author":"AE Espinosa De Ycaza","year":"2017","unstructured":"Espinosa De Ycaza AE, Welch TL, Ospina NS et al (2017) Image-guided thermal ablation of adrenal metastases: hemodynamic and endocrine outcomes. Endocr Pract 23:132\u2013140. https:\/\/doi.org\/10.4158\/EP161498.OR","journal-title":"Endocr Pract"},{"key":"1841_CR31","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.eururo.2014.10.010","volume":"67","author":"S Loeb","year":"2015","unstructured":"Loeb S, Bruinsma SM, Nicholson J et al (2015) Active surveillance for prostate cancer: a systematic review of clinicopathologic variables and biomarkers for risk stratification. Eur Urol 67:619\u2013626. https:\/\/doi.org\/10.1016\/j.eururo.2014.10.010","journal-title":"Eur Urol"},{"key":"1841_CR32","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.3390\/medicina59091589","volume":"59","author":"V Ramalingam","year":"2023","unstructured":"Ramalingam V, McCarthy CJ, Degerstedt S, Ahmed M (2023) Image-guided prostate cryoablation: state-of-the-art. Medicina (Kaunas) 59:1589. https:\/\/doi.org\/10.3390\/medicina59091589","journal-title":"Medicina (Kaunas)"},{"key":"1841_CR33","doi-asserted-by":"publisher","first-page":"3873","DOI":"10.3390\/cancers15153873","volume":"15","author":"CH Chen","year":"2023","unstructured":"Chen CH, Tsai CY, Pu YS (2023) Primary total prostate cryoablation for localized high-risk prostate cancer: 10-year outcomes and nomograms. Cancers (Basel) 15:3873. https:\/\/doi.org\/10.3390\/cancers15153873","journal-title":"Cancers (Basel)"},{"key":"1841_CR34","doi-asserted-by":"publisher","first-page":"48","DOI":"10.4103\/ua.ua_171_21","volume":"15","author":"O Selvaggio","year":"2023","unstructured":"Selvaggio O, Falagario UG, Finati M et al (2023) Oncological outcomes of whole-gland cryoablation in patients with prostate cancer and high risk of lymph node invasion. Urol Ann 15:48\u201353. https:\/\/doi.org\/10.4103\/ua.ua_171_21","journal-title":"Urol Ann"},{"key":"1841_CR35","doi-asserted-by":"publisher","unstructured":"Khan A, Khan AU, Siref L, Feloney M (2023) Focal cryoablation of the prostate: primary treatment in 163 patients with localized prostate cancer. Cureus. https:\/\/doi.org\/10.7759\/cureus.37172","DOI":"10.7759\/cureus.37172"},{"key":"1841_CR36","doi-asserted-by":"publisher","first-page":"3824","DOI":"10.1002\/cncr.34458","volume":"128","author":"WP Tan","year":"2022","unstructured":"Tan WP, Kotamarti S, Chen E et al (2022) Oncological and functional outcomes of men undergoing primary whole gland cryoablation of the prostate: a 20-year experience. Cancer 128:3824\u20133830. https:\/\/doi.org\/10.1002\/cncr.34458","journal-title":"Cancer"},{"key":"1841_CR37","doi-asserted-by":"publisher","first-page":"150.e1","DOI":"10.1016\/j.urolonc.2016.11.008","volume":"35","author":"M Valerio","year":"2017","unstructured":"Valerio M, Shah TT, Shah P et al (2017) Magnetic resonance imaging-transrectal ultrasound fusion focal cryotherapy of the prostate: a prospective development study. Urol Oncol 35:150.e1\u2013150.e7. https:\/\/doi.org\/10.1016\/j.urolonc.2016.11.008","journal-title":"Urol Oncol"},{"key":"1841_CR38","doi-asserted-by":"publisher","first-page":"2988","DOI":"10.3390\/cancers14122988","volume":"14","author":"E Fern\u00e1ndez-Pascual","year":"2022","unstructured":"Fern\u00e1ndez-Pascual E, Manfredi C, Mart\u00edn C et al (2022) MRI-US fusion-guided targeted cryotherapy in patients with primary localized prostate cancer: a prospective analysis of oncological and functional outcomes. Cancers (Basel) 14:2988. https:\/\/doi.org\/10.3390\/cancers14122988","journal-title":"Cancers (Basel)"},{"key":"1841_CR39","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1007\/s00345-023-04352-9","volume":"41","author":"G Duwe","year":"2023","unstructured":"Duwe G, Boehm K, Haack M et al (2023) Single-center, prospective phase 2 trial of high-intensity focused ultrasound (HIFU) in patients with unilateral localized prostate cancer: good functional results but oncologically not as safe as expected. World J Urol 41:1293\u20131299. https:\/\/doi.org\/10.1007\/s00345-023-04352-9","journal-title":"World J Urol"},{"key":"1841_CR40","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.euf.2022.10.006","volume":"9","author":"N Westhoff","year":"2023","unstructured":"Westhoff N, Ernst R, Kowalewski KF et al (2023) Medium-term oncological efficacy and patient-reported outcomes after focal high-intensity focused ultrasound: the FOXPRO trial. Eur Urol Focus 9:283\u2013290. https:\/\/doi.org\/10.1016\/j.euf.2022.10.006","journal-title":"Eur Urol Focus"},{"key":"1841_CR41","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1007\/s11255-022-03156-x","volume":"54","author":"K Lo Verde","year":"2022","unstructured":"Lo Verde K, Toledano H, Campagna J, Rossi D, Bastide C, Baboudjian M (2022) Long-term outcomes of whole gland high-intensity focused ultrasound for localized prostate cancer. Int Urol Nephrol 54:1233\u20131238. https:\/\/doi.org\/10.1007\/s11255-022-03156-x","journal-title":"Int Urol Nephrol"},{"key":"1841_CR42","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1001\/jamasurg.2022.7516","volume":"158","author":"K Zhang","year":"2023","unstructured":"Zhang K, Teoh J, Laguna P et al (2023) Effect of focal vs extended irreversible electroporation for the ablation of localized low- or intermediate-risk prostate cancer on early oncological control: a randomized clinical trial. JAMA Surg 158:343. https:\/\/doi.org\/10.1001\/jamasurg.2022.7516","journal-title":"JAMA Surg"},{"key":"1841_CR43","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/bju.15946","volume":"131","author":"MJ Scheltema","year":"2023","unstructured":"Scheltema MJ, Geboers B, Blazevski A et al (2023) Median 5-year outcomes of primary focal irreversible electroporation for localised prostate cancer. BJU Int 131:6\u201313. https:\/\/doi.org\/10.1111\/bju.15946","journal-title":"BJU Int"},{"key":"1841_CR44","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s10147-020-01847-y","volume":"26","author":"RQ Guo","year":"2021","unstructured":"Guo RQ, Guo XX, Li YM, Bie ZX, Li B, Li XG (2021) Cryoablation, high-intensity focused ultrasound, irreversible electroporation, and vascular-targeted photodynamic therapy for prostate cancer: a systemic review and meta-analysis. Int J Clin Oncol 26:461\u2013484. https:\/\/doi.org\/10.1007\/s10147-020-01847-y","journal-title":"Int J Clin Oncol"},{"key":"1841_CR45","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.jvir.2023.09.029","volume":"35","author":"V Ramalingam","year":"2024","unstructured":"Ramalingam V, Degerstedt S, Moussa M, Tsai LL, Einstein D, Ahmed M (2024) Percutaneous CT-guided cryoablation for locally recurrent prostate cancer: technical feasibility, safety, and effectiveness. J Vasc Interv Radiol 35:36\u201344. https:\/\/doi.org\/10.1016\/j.jvir.2023.09.029","journal-title":"J Vasc Interv Radiol"},{"key":"1841_CR46","doi-asserted-by":"publisher","first-page":"4093","DOI":"10.3390\/cancers15164093","volume":"15","author":"Y Wimper","year":"2023","unstructured":"Wimper Y, Overduin CG, Sedelaar JPM et al (2023) MRI-guided salvage focal cryoablation: a 10-year single-center experience in 114 patients with localized recurrent prostate cancer. Cancers (Basel) 15:4093. https:\/\/doi.org\/10.3390\/cancers15164093","journal-title":"Cancers (Basel)"},{"key":"1841_CR47","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.euo.2023.02.007","volume":"6","author":"WP Tan","year":"2023","unstructured":"Tan WP, Kotamarti S, Ayala A et al (2023) Oncological and functional outcomes for men undergoing salvage whole-gland cryoablation for radiation-resistant prostate cancer. Eur Urol Oncol 6:289\u2013294. https:\/\/doi.org\/10.1016\/j.euo.2023.02.007","journal-title":"Eur Urol Oncol"},{"key":"1841_CR48","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1111\/bju.15269","volume":"128","author":"L Exterkate","year":"2021","unstructured":"Exterkate L, Peters M, Somford DM, Vergunst H (2021) Functional and oncological outcomes of salvage cryosurgery for radiorecurrent prostate cancer. BJU Int 128:46\u201356. https:\/\/doi.org\/10.1111\/bju.15269","journal-title":"BJU Int"},{"key":"1841_CR49","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/bju.15947","volume":"131","author":"A Blazevski","year":"2023","unstructured":"Blazevski A, Geboers B, Scheltema MJ et al (2023) Salvage irreversible electroporation for radio-recurrent prostate cancer\u2014the prospective FIRE trial. BJU Int 131:23\u201331. https:\/\/doi.org\/10.1111\/bju.15947","journal-title":"BJU Int"},{"key":"1841_CR50","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/bju.15948","volume":"131","author":"B Geboers","year":"2023","unstructured":"Geboers B, Scheltema MJ, Blazevski A et al (2023) Median 4-year outcomes of salvage irreversible electroporation for localized radio-recurrent prostate cancer. BJU Int 131:14\u201322. https:\/\/doi.org\/10.1111\/bju.15948","journal-title":"BJU Int"},{"key":"1841_CR51","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1093\/humrep\/16.7.1489","volume":"16","author":"H Fernandez","year":"2001","unstructured":"Fernandez H, Sefrioui O, Virelizier C, Gervaise A, Gomel V, Frydman R (2001) Hysteroscopic resection of submucosal myomas in patients with infertility. Hum Reprod 16:1489\u20131492. https:\/\/doi.org\/10.1093\/humrep\/16.7.1489","journal-title":"Hum Reprod"},{"key":"1841_CR52","doi-asserted-by":"publisher","first-page":"426","DOI":"10.12891\/ceog19372014","volume":"41","author":"P Litta","year":"2014","unstructured":"Litta P, Saccardi C, Tommasi L, Di Giuseppe J, Delli Carpini G, Ciavattini A (2014) Risk of recurrent menorrhagia after hydrothermoablation: role of GnRH analogues neoadjuvant treatment in long-term successful rate. Clin Exp Obstet Gynecol 41:426\u2013431","journal-title":"Clin Exp Obstet Gynecol"},{"key":"1841_CR53","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/s0015-0282(16)47951-3","volume":"42","author":"CR Garcia","year":"1984","unstructured":"Garcia CR, Tureck RW (1984) Submucosal leiomyomas and infertility. Fertil Steril 42:16\u201319. https:\/\/doi.org\/10.1016\/s0015-0282(16)47951-3","journal-title":"Fertil Steril"},{"key":"1841_CR54","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1016\/0002-9378(90)90909-q","volume":"162","author":"DC Smith","year":"1990","unstructured":"Smith DC, Uhlir JK (1990) Myomectomy as a reproductive procedure. Am J Obstet Gynecol 162:1476\u20131482. https:\/\/doi.org\/10.1016\/0002-9378(90)90909-q","journal-title":"Am J Obstet Gynecol"},{"key":"1841_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/s0015-0282(16)55128-0","volume":"58","author":"BS Verkauf","year":"1992","unstructured":"Verkauf BS (1992) Myomectomy for fertility enhancement and preservation. Fertil Steril 58:1\u201315. https:\/\/doi.org\/10.1016\/s0015-0282(16)55128-0","journal-title":"Fertil Steril"},{"key":"1841_CR56","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/0301-2115(95)02363-1","volume":"65","author":"R Sudik","year":"1996","unstructured":"Sudik R, H\u00fcsch K, Steller J, Daume E (1996) Fertility and pregnancy outcome after myomectomy in sterility patients. Eur J Obstet Gynecol Reprod Biol 65:209\u2013214. https:\/\/doi.org\/10.1016\/0301-2115(95)02363-1","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"1841_CR57","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/s1074-3804(05)80230-0","volume":"4","author":"MH Glasser","year":"1997","unstructured":"Glasser MH (1997) Endometrial ablation and hysteroscopic myomectomy by electrosurgical vaporization. J Am Assoc Gynecol Laparosc 4:369\u2013374. https:\/\/doi.org\/10.1016\/s1074-3804(05)80230-0","journal-title":"J Am Assoc Gynecol Laparosc"},{"key":"1841_CR58","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1289\/ehp.00108s5835","volume":"108","author":"AF Haney","year":"2000","unstructured":"Haney AF (2000) Clinical decision making regarding leiomyomata: what we need in the next millenium. Environ Health Perspect 108:835\u2013839. https:\/\/doi.org\/10.1289\/ehp.00108s5835","journal-title":"Environ Health Perspect"},{"key":"1841_CR59","first-page":"39","volume":"7","author":"JL Mu\u00f1oz","year":"2003","unstructured":"Mu\u00f1oz JL, Jim\u00e9nez JS, Hern\u00e1ndez C et al (2003) Hysteroscopic myomectomy: our experience and review. JSLS 7:39\u201348","journal-title":"JSLS"},{"key":"1841_CR60","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1111\/j.0001-6349.2005.00690.x","volume":"84","author":"S Campo","year":"2005","unstructured":"Campo S, Campo V, Gambadauro P (2005) Short-term and long-term results of resectoscopic myomectomy with and without pretreatment with GnRH analogs in premenopausal women. Acta Obstet Gynecol Scand 84:756\u2013760. https:\/\/doi.org\/10.1111\/j.0001-6349.2005.00690.x","journal-title":"Acta Obstet Gynecol Scand"},{"key":"1841_CR61","doi-asserted-by":"publisher","first-page":"149","DOI":"10.5603\/GP.2020.0032","volume":"91","author":"Y Wang","year":"2020","unstructured":"Wang Y, Zhang S, Li C, Li B, Ouyang L (2020) Minimally invasive surgery for uterine fibroids. Ginekol Pol 91:149\u2013157. https:\/\/doi.org\/10.5603\/GP.2020.0032","journal-title":"Ginekol Pol"},{"key":"1841_CR62","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1053\/j.sult.2020.08.004","volume":"42","author":"AM Ierardi","year":"2021","unstructured":"Ierardi AM, Carnevale A, Pellegrino F et al (2021) Uterine myomas: extravascular treatment. Semin Ultrasound CT MR 42:56\u201374. https:\/\/doi.org\/10.1053\/j.sult.2020.08.004","journal-title":"Semin Ultrasound CT MR"},{"key":"1841_CR63","doi-asserted-by":"publisher","unstructured":"Zhang J, Han ZY, Feng L et al (2011) [Ultrasound-guided percutaneous microwave ablation in the treatment of diffuse adenomyosis]. Zhonghua Yi Xue Za Zhi. https:\/\/doi.org\/10.3760\/cma.j.issn.0376-2491.2011.39.005","DOI":"10.3760\/cma.j.issn.0376-2491.2011.39.005"},{"key":"1841_CR64","doi-asserted-by":"publisher","unstructured":"Wang F, Zhang J, Han ZY et al (2021) Imaging manifestation of conventional and contrast-enhanced ultrasonography in percutaneous microwave ablation for the treatment of uterine fibroids. Eur J Radiol. https:\/\/doi.org\/10.1016\/j.ejrad.2011.12.037","DOI":"10.1016\/j.ejrad.2011.12.037"},{"key":"1841_CR65","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1016\/j.jmig.2021.06.020","volume":"28","author":"L Liu","year":"2021","unstructured":"Liu L, Wang T, Lei B (2021) Ultrasound-guided microwave ablation in the management of symptomatic uterine myomas: a systematic review and meta-analysis. J Minim Invasive Gynecol 28:1982\u20131992. https:\/\/doi.org\/10.1016\/j.jmig.2021.06.020","journal-title":"J Minim Invasive Gynecol"},{"key":"1841_CR66","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1007\/s00330-021-08156-6","volume":"32","author":"L Liu","year":"2022","unstructured":"Liu L, Wang T, Lei B (2022) High-intensity focused ultrasound (HIFU) ablation versus surgical interventions for the treatment of symptomatic uterine fibroids: a meta-analysis. Eur Radiol 32:1195\u20131204. https:\/\/doi.org\/10.1007\/s00330-021-08156-6","journal-title":"Eur Radiol"},{"key":"1841_CR67","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.jmig.2020.11.004","volume":"28","author":"L Liu","year":"2021","unstructured":"Liu L, Wang T, Lei B (2021) Uterine artery embolization compared with high-intensity focused ultrasound ablation for the treatment of symptomatic uterine myomas: a systematic review and meta-analysis. J Minim Invasive Gynecol 28:218\u2013227. https:\/\/doi.org\/10.1016\/j.jmig.2020.11.004","journal-title":"J Minim Invasive Gynecol"},{"key":"1841_CR68","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1089\/lap.2019.0550","volume":"29","author":"LD Bradley","year":"2019","unstructured":"Bradley LD, Pasic RP, Miller LE (2019) Clinical performance of radiofrequency ablation for treatment of uterine fibroids: systematic review and meta-analysis of prospective studies. J Laparoendosc Adv Surg Tech A 29:1507\u20131517. https:\/\/doi.org\/10.1089\/lap.2019.0550","journal-title":"J Laparoendosc Adv Surg Tech A"},{"key":"1841_CR69","doi-asserted-by":"publisher","first-page":"108700","DOI":"10.1016\/j.ejrad.2019.108700","volume":"120","author":"IM Verpalen","year":"2019","unstructured":"Verpalen IM, Anneveldt KJ, Nijholt IM et al (2019) Magnetic resonance high intensity focused ultrasound (MR-HIFU) therapy of symptomatic uterine fibroids with unrestrictive treatment protocols: a systematic review and meta-analysis. Eur J Radiol 120:108700. https:\/\/doi.org\/10.1016\/j.ejrad.2019.108700","journal-title":"Eur J Radiol"},{"key":"1841_CR70","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/2360107","volume":"2018","author":"AM Ierardi","year":"2018","unstructured":"Ierardi AM, Savasi V, Angileri SA et al (2018) Percutaneous high frequency microwave ablation of uterine fibroids: systematic review. Biomed Res Int 2018:1\u20139. https:\/\/doi.org\/10.1155\/2018\/2360107","journal-title":"Biomed Res Int"},{"key":"1841_CR71","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s13669-017-0194-2","volume":"6","author":"DB Toub","year":"2017","unstructured":"Toub DB (2017) A new paradigm for uterine fibroid treatment: transcervical, intrauterine sonography-guided radiofrequency ablation of uterine fibroids with the sonata system. Curr Obstet Gynecol Rep 6:67\u201373. https:\/\/doi.org\/10.1007\/s13669-017-0194-2","journal-title":"Curr Obstet Gynecol Rep"},{"key":"1841_CR72","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1002\/uog.1861","volume":"25","author":"C Exacoustos","year":"2005","unstructured":"Exacoustos C, Zupi E, Marconi D et al (2005) Ultrasound-assisted laparoscopic cryomyolysis: two- and three-dimensional findings before, during and after treatment. Ultrasound Obstet Gynecol 25:393\u2013400. https:\/\/doi.org\/10.1002\/uog.1861","journal-title":"Ultrasound Obstet Gynecol"},{"key":"1841_CR73","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1093\/humrep\/17.10.2737","volume":"17","author":"JT Hindley","year":"2002","unstructured":"Hindley JT, Law PA, Hickey M et al (2002) Clinical outcomes following percutaneous magnetic resonance image guided laser ablation of symptomatic uterine fibroids. Hum Reprod 17:2737\u20132741. https:\/\/doi.org\/10.1093\/humrep\/17.10.2737","journal-title":"Hum Reprod"}],"container-title":["Insights into Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13244-024-01841-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13244-024-01841-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13244-024-01841-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T09:03:33Z","timestamp":1731056613000},"score":1,"resource":{"primary":{"URL":"https:\/\/insightsimaging.springeropen.com\/articles\/10.1186\/s13244-024-01841-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,8]]},"references-count":73,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1841"],"URL":"https:\/\/doi.org\/10.1186\/s13244-024-01841-2","relation":{},"ISSN":["1869-4101"],"issn-type":[{"type":"electronic","value":"1869-4101"}],"subject":[],"published":{"date-parts":[[2024,11,8]]},"assertion":[{"value":"27 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No ethical approval was required due to the review nature of the article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All Authors agree with the publication of the paper.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"267"}}